﻿<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="rssNews.xsl"?>
<rss version="2.0">
   <channel>
      <title>Diamyd News &amp; Mediawatch</title>
      <link>http://www.diamyd.com/</link>
      <description>Latest news on Diamyd Medical activities and events and links to worldwide news sources with articles on Diamyd Medical. Diamyd develops pharmaceuticals for the treatment of autoimmune diabetes and its complications. Our vision is to one day be able to prevent and cure the autoimmune form of diabetes. Diamyd's lead product, the diabetes vaccine Diamyd® has shown to significantly slow down the disease process.</description>
      <copyright>Copyright Diamyd Medical AB 2012. All rights reserved.</copyright>
      <atom:link href="http://www.diamyd.com/rssNews.aspx" rel="self" type="application/rss+xml" xmlns:atom="http://www.w3.org/2005/Atom" />
      <item>
         <title>Fri, Feb 03, 2012 - Sweden - LiU.se: Do seasonal changes influence the efficacy of vaccination against diabetes? </title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=388</link>
         <description><![CDATA[The development of a medicine for patients with type 1 diabetes mellitus, based on autoantigen GAD65, received a setback following crucial clinical phase 3 trials that failed to show significant effects. One possible explanation may be...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=388</guid>
         <pubDate>Fri, 03 Feb 2012 10:04:04 +0100</pubDate>
      </item>
      <item>
         <title>Thu, Feb 02, 2012 - Sweden - LiU.se: "Vi tror ännu på diabetesvaccinet"</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=387</link>
         <description><![CDATA[Utvecklingen av ett läkemedel mot typ 1-diabetes, baserat på autoantigenet GAD65, fick ett avbräck sedan den avgörande kliniska prövningen inte visade tillräckligt tydlig effekt. En tänkbar orsak kan vara årstidsvariationer i immunsystemet,...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=387</guid>
         <pubDate>Thu, 02 Feb 2012 11:51:23 +0100</pubDate>
      </item>
      <item>
         <title>Thu, Feb 02, 2012 - USA - healthfinder.gov: Type 1 Diabetes Treatment Disappoints in Trial</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=386</link>
         <description><![CDATA[WEDNESDAY, Feb. 1 (HealthDay News) -- The latest trial of a drug called GAD-alum to treat type 1 diabetes failed to show any significant improvement in the common markers of the blood sugar disease. The researchers, however, said they felt...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=386</guid>
         <pubDate>Thu, 02 Feb 2012 11:50:32 +0100</pubDate>
      </item>
      <item>
         <title>Thu, Feb 02, 2012 - USA - medpagetoday.com: Autoantigen Tx Benefits Some Type 1 Diabetics</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=385</link>
         <description><![CDATA[Autoantigen treatment of new-onset type 1 diabetes was unsuccessful in preserving pancreatic beta-cell function overall, but the treatment did appear to help in certain prespecified patient subgroups, a phase III European study found.<br...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=385</guid>
         <pubDate>Thu, 02 Feb 2012 11:49:27 +0100</pubDate>
      </item>
      <item>
         <title>Fri, Jan 27, 2012 - Sweden - Redeye.se: Diamyd Medical: Inget nytt i rapporten</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=384</link>
         <description><![CDATA[Bolagets rapport för första kvartalet i det brutna räkenskapsåret 2011/12 innehöll inga stora överraskningar. För perioden hade bolaget obefintliga intäkter och kostnader på nästan 16 miljoner kronor. Vi uppskattar att knappt hälften av...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=384</guid>
         <pubDate>Fri, 27 Jan 2012 10:23:11 +0100</pubDate>
      </item>
      <item>
         <title>Tue, Jan 17, 2012 - Sweden - Diabetesportalen.se: "Finns det ett virus där kommer vi att hitta det"</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=383</link>
         <description><![CDATA[Frågan vad som startar immunsystemets attack och förstör de insulinproducerande cellerna har gäckat forskarna i många år. Kanske svaret finns hos de 24 TEDDY-barn som mycket snabbt insjuknat i typ 1 diabetes.<br /> <br /> - Det snabba...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=383</guid>
         <pubDate>Tue, 17 Jan 2012 15:31:24 +0100</pubDate>
      </item>
      <item>
         <title>Thu, Dec 15, 2011 - Sweden - LiU.se: GAD-vaccin ger immunologiskt minne</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=382</link>
         <description><![CDATA[Ännu efter fyra år kvarstår effekter av behandlingen med GAD-alum-vaccin (Diamyd(r)) hos barn med typ 1-diabetes. Fynden ger hopp om att kunna vidareutveckla vaccinet för att i framtiden kunna bromsa sjukdomsförloppet. Det är en...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=382</guid>
         <pubDate>Thu, 15 Dec 2011 11:49:07 +0100</pubDate>
      </item>
      <item>
         <title>Wed, Nov 16, 2011 - Sweden - BiotechSweden: Diamyd ökar trots turbulens</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=381</link>
         <description><![CDATA[Efter att bolagets huvudprojekt kraschat tidigare i år visar Diamyd ändå positiva resultat under räkenskapsåret. Nu hoppas de hitta en ny partner.<br /> <br /> <a href="http://biotech.idg.se/2.1763/1.416582/diamyd-okar-trots-turbulens"...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=381</guid>
         <pubDate>Wed, 16 Nov 2011 16:33:55 +0100</pubDate>
      </item>
      <item>
         <title>Tue, Oct 25, 2011 - Sweden - Redeye: Diamyd Medical: Odramatisk rapport i nivå med förväntan</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=380</link>
         <description><![CDATA[Rapporten för sista kvartalet i det brutna räkenskapsåret 2010/11 var i nivå med våra estimat. Kostnaderna uppgick för perioden till 36,5 miljoner kronor jämfört med förväntat 35,5 miljoner kronor samtidigt som intäkterna var något högre...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=380</guid>
         <pubDate>Tue, 25 Oct 2011 09:44:53 +0100</pubDate>
      </item>
      <item>
         <title>Mon, Oct 03, 2011 - Sweden - Sydsvenskan: Utmaningen: hitta rätt bit i diabetespusslet</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=379</link>
         <description><![CDATA[Diabetes ökar snabbt bland europeiska barn. Sverige och Finland har flest drabbade. Barnen får också sjukdomen allt tidigare i livet. I Finland är debutåldern under åtta år. Forskarna lägger pussel för att lösa diabetesgåtan. I Skåne pågår...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=379</guid>
         <pubDate>Mon, 03 Oct 2011 09:21:08 +0100</pubDate>
      </item>
      <item>
         <title>Mon, Sep 26, 2011 - USA - University of Michigan earns $3 million grant to develop treatment for nerve damage</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=378</link>
         <description><![CDATA[David Fink, M.D., chair of the University of Michigan Department of Neurology, has been awarded a $3 million grant from the National Institutes of Health to develop a new treatment for preventing nerve damage known as neuropathy.<br /> <br ...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=378</guid>
         <pubDate>Mon, 26 Sep 2011 17:54:43 +0100</pubDate>
      </item>
      <item>
         <title>Tue, Sep 13, 2011 - Sweden - Redeye: Diamyd Medical har beviljats stöd för ett projekt. Vi ger vår syn på aktien</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=377</link>
         <description><![CDATA["...Vi värderar Diamyd Medical till 24 kronor per aktie. De resultat vi hittills sett från NP2 är mycket lovande och vi ser en betydande uppsida i aktien. Givet den redan höga värderingsrabatten och att aktien handlas betydligt under...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=377</guid>
         <pubDate>Tue, 13 Sep 2011 17:16:44 +0100</pubDate>
      </item>
      <item>
         <title>Thu, Aug 18, 2011 - Sweden - KemivärldenBiotech.se: Diamyd säger upp personal</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=376</link>
         <description><![CDATA[Diamyd Medical avvecklar fas III-programmet med sitt diabetesvaccin och säger därmed upp de flesta anställda på Sverigekontoret. Nu fokuserar bolaget i stället på sin smärtteknologi som utvecklas i USA.<br /> <br /> <a...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=376</guid>
         <pubDate>Thu, 18 Aug 2011 14:52:21 +0100</pubDate>
      </item>
      <item>
         <title>Mon, Jul 25, 2011 - Sweden - Company analysis by Redeye: Diamyd Medical: Time to look forward</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=375</link>
         <description><![CDATA["After the negative results from the Phase III studies of Diamyd(r), the company has decided to close the trials, and this is expected to quickly reduce costs. In our view, Diamyd Medical is now a gene therapy company whose most advanced...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=375</guid>
         <pubDate>Mon, 25 Jul 2011 11:08:31 +0100</pubDate>
      </item>
      <item>
         <title>Wed, Jul 06, 2011 - Sweden - Bolagsanalys av Redeye: Diamyd Medical: Dags att blicka framåt</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=374</link>
         <description><![CDATA["Efter de negativa beskeden från fas III-studierna med Diamyd(r) har bolaget tagit beslut att stänga dessa, vilket snabbt väntas reducera kostnaderna. Diamyd Medical är nu i våra ögon ett genterapibolag där det längst framskridna projektet...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=374</guid>
         <pubDate>Wed, 06 Jul 2011 10:44:49 +0100</pubDate>
      </item>
      <item>
         <title>Fri, Jul 01, 2011 - Sweden - LiU.se: Ljus i mörkret för diabetesvaccin</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=373</link>
         <description><![CDATA[Vaccinering med antigenet GAD verkar inte ensamt kunna bromsa utvecklingen av typ 1-diabetes. Ytterligare en studie, utförd i Nordamerika, visar nu negativa resultat som publiceras i tidskriften Lancet. Författarna tror ändå att...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=373</guid>
         <pubDate>Fri, 01 Jul 2011 13:31:30 +0100</pubDate>
      </item>
      <item>
         <title>Fri, Jul 01, 2011 - Sweden - LiU.se: New setback for diabetes vaccine</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=372</link>
         <description><![CDATA[Vaccination with the antigen GAD does not, in isolation, appear to be able to restrict the progression of type-1 diabetes. Another study, conducted in North America and published in the journal Lancet, also indicates negative results. The...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=372</guid>
         <pubDate>Fri, 01 Jul 2011 13:30:26 +0100</pubDate>
      </item>
      <item>
         <title>Thu, Jun 23, 2011 - Sweden - BioTech Sweden: Diamyd avbryter USA-studie</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=371</link>
         <description><![CDATA[<strong></strong>Diamyd medicals preparat för behandling och prevention av typ 1-diabetes visade negativa resultat i en europeisk fas III-studie. Nu visar en analys av effektdatan från en liknande fas III-studie i USA att preparatet...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=371</guid>
         <pubDate>Thu, 23 Jun 2011 17:13:15 +0100</pubDate>
      </item>
      <item>
         <title>Tue, Jun 21, 2011 - Sweden - Lund University Diabetes Centre: Still hope for GAD diabetes vaccine</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=370</link>
         <description><![CDATA[Despite the disappointing results in trying to treat children suffering from type 1 diabetes with the GAD vaccine, the treatment has not been written off entirely. DIAPREV-IT, the study in which healthy high-risk children are vaccinated, is...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=370</guid>
         <pubDate>Tue, 21 Jun 2011 16:31:20 +0100</pubDate>
      </item>
      <item>
         <title>Fri, Jun 17, 2011 - Sweden - Diabetesportalen.se: Än är inte hoppet om diabetesvaccinet ute</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=369</link>
         <description><![CDATA[Trots det nedslående resultatet att försöka behandla barn som insjuknat i typ 1 diabetes med GAD-vaccin är inte behandlingen helt avskriven. DIAPREV-IT, undersökningen där friska högriskbarn vaccineras, fortsätter som planerat och nu med...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=369</guid>
         <pubDate>Fri, 17 Jun 2011 10:31:30 +0100</pubDate>
      </item>
      <item>
         <title>Tue, May 31, 2011 - USA - Diamyd presents at World Pharma Congress </title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=368</link>
         <description><![CDATA[Darren Wolfe, CEO of Diamyd Inc, presents the Companys NP2 therapy for severe pain at the World Pharma Congress in Philadelphia, PA, June 7, 2011. Diamyd Inc has developed replication defective HSV vectors for clinical use and have...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=368</guid>
         <pubDate>Tue, 31 May 2011 11:11:22 +0100</pubDate>
      </item>
      <item>
         <title>Fri, May 27, 2011 - USA - Neurologix's follow-up data on the GAD-based drug candidate NLX-P101 confirm sustained, positive long-term efficacy in Parkinson patients</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=367</link>
         <description><![CDATA[Diamyd Medicals license partner Neurologix has presented one-year follow-up data from a Phase II study of the GAD-based drug candidate NLX-P101, at the International Neuromodulation Societys 10th World Congress in London. <br /> <br /> In...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=367</guid>
         <pubDate>Fri, 27 May 2011 10:26:43 +0100</pubDate>
      </item>
      <item>
         <title>Wed, May 25, 2011 - Sweden - Webcast från Avanza Banks &amp; Redeyes Börsdagar i Stockholm </title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=366</link>
         <description><![CDATA[Företagspresentation av tf VD Peter Zerhouni från Avanza Banks Redeyes Börsdagar på Hamburger Börs i Stockholm, den 25 maj. Dagarna arrangeras i samarbete med Financial Hearings.<br /> <br /> <a...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=366</guid>
         <pubDate>Wed, 25 May 2011 14:42:39 +0100</pubDate>
      </item>
      <item>
         <title>Mon, May 23, 2011 - Sweden - Biotech Sweden: Diamyd Medical håller andan - intervju med Peter Zerhouni</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=365</link>
         <description><![CDATA[Efter negativa studieresultat störtdök aktien. Biotech Sweden har pratat med Peter Zerhouni, tf vd på Diamyd, om hur de ska klara sig ur krisen. <br /> <br /> - Just nu inväntar vi resultat från en fas II-studie som genomförs i USA med 126 ...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=365</guid>
         <pubDate>Mon, 23 May 2011 16:22:58 +0100</pubDate>
      </item>
      <item>
         <title>Mon, May 23, 2011 - USA - Videocast from ASGCT 2011: Darren Wolfe on gene therapy for pain</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=364</link>
         <description><![CDATA[Nick Lemoine Joe Glorioso, Editors of Gene Therapy, the Nature Specialist Journal interviewed a series of leading scientists presenting exciting results at the American Society of Gene Cell Therapy in Seattle in May 2011. Here Darren...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=364</guid>
         <pubDate>Mon, 23 May 2011 10:56:08 +0100</pubDate>
      </item>
      <item>
         <title>Thu, May 19, 2011 - Sweden - Diamyd medverkar på Avanza Banks &amp; Redeyes Börsdagar</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=363</link>
         <description><![CDATA[Diamyd Medical är ett av flera industri- och life sciencebolag som presenterar på Avanza Banks Redeyes Börsdagar den 25-26 maj 2010. Diamyd Medicals tillförordnade VD Peter Zerhouni kommer att presentera bolaget kl 8.30 den 25 maj.<br />...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=363</guid>
         <pubDate>Thu, 19 May 2011 09:53:03 +0100</pubDate>
         <enclosure url="http://www.diamyd.com/docs/pdf/Program_Avanza_Banks-Redeyes_Borsdagar_25-26_maj-2011.pdf" length="125011" type="application/pdf" />
      </item>
      <item>
         <title>Wed, May 18, 2011 - France - Diamyd Medical presents at BioEquity Europe 2011</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=362</link>
         <description><![CDATA[Diamyd Medical's Acting President and CEO, Peter Zerhouni, will give a company presentation at the 12th Annual Meeting BioEquity Europe 2011 on May 23 at 14.30. The forum is arranged by BioCentury at the Paris Marriott Rive Gauche in Paris,...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=362</guid>
         <pubDate>Wed, 18 May 2011 19:34:57 +0100</pubDate>
      </item>
      <item>
         <title>Tue, May 17, 2011 - Sweden - Company analysis by Redeye: Diamyd Medical: Heavy blow</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=361</link>
         <description><![CDATA["Diamyd Medicals Phase III study did not reach the primary endpoint of preserving beta cell function at 15 months. We see no reason why the results from the other Phase III study in the US would be any different, so we have reduced...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=361</guid>
         <pubDate>Tue, 17 May 2011 11:51:26 +0100</pubDate>
      </item>
      <item>
         <title>Thu, May 12, 2011 - Sweden - LiU.se: Bakslag för diabetesvaccin</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=360</link>
         <description><![CDATA[En stor europeisk studie som testar vaccinet Diamyd mot diabetes typ 1 kan hittills inte påvisa att behandlingen är effektiv.<br /> <br /> Det är en stor besvikelse att studien inte uppnådde signifikant effekt. Även om behandlingen kan ha...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=360</guid>
         <pubDate>Thu, 12 May 2011 14:42:14 +0100</pubDate>
      </item>
      <item>
         <title>Tue, May 10, 2011 - Sweden - Bolagsanalys av Redeye: Diamyd Medical: Tungt bakslag</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=359</link>
         <description><![CDATA["Diamyd Medicals fas III-studie nådde inte det primära målet att bevara betacellsfunktion efter 15 månader. Vi har svårt att se varför resultaten från den andra amerikanska fas III-studien skulle visa annat än liknande resultat och har därf...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=359</guid>
         <pubDate>Tue, 10 May 2011 12:15:45 +0100</pubDate>
      </item>
      <item>
         <title>Fri, May 06, 2011 - Sweden - Company analysis by Redeye: Diamyd Medical: Turbulence ahead of decision</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=358</link>
         <description><![CDATA["The figures for the second quarter were in line with our forecasts. Diamyd Medical is in a strong financial position ahead of the impending and crucial phase III decisions. Management changes caused by the sudden departure of former...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=358</guid>
         <pubDate>Fri, 06 May 2011 14:11:37 +0100</pubDate>
      </item>
      <item>
         <title>Mon, May 02, 2011 - Sweden - Bolagsanalys av Redeye: Turbulent inför besked</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=357</link>
         <description><![CDATA["Andra kvartalets siffror var i nivå med våra prognoser. Diamyd Medical har en stark finansiell situation inför de nära förestående och avgörande fas III-beskeden. Ledningsförändringar med en hastig sorti för tidigare vd Elisabeth Linder...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=357</guid>
         <pubDate>Mon, 02 May 2011 09:15:34 +0100</pubDate>
      </item>
      <item>
         <title>Tue, Apr 26, 2011 - Sweden - va.se: Diamyd-genombrott kan vara nära</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=356</link>
         <description><![CDATA[" Spänningen ökar när det snart är dags för bioteknikbolaget Diamyd Medical att presentera de första preliminära resultaten från sin fas III-studie med läkemedelskandidaten Diamyd.<br /> <br /> I mitten av februari gjorde den sista...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=356</guid>
         <pubDate>Tue, 26 Apr 2011 10:26:08 +0100</pubDate>
      </item>
      <item>
         <title>Thu, Apr 14, 2011 - USA - Michigandaily.com: Study shows gene therapy an effective treatment of pain in cancer patients</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=355</link>
         <description><![CDATA[Morphine and other pain medications that lead to addiction have been used for decades to treat pain associated with various forms of cancer. But University researchers recently found that gene therapy can serve a similar purpose by...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=355</guid>
         <pubDate>Thu, 14 Apr 2011 10:43:38 +0100</pubDate>
      </item>
      <item>
         <title>Tue, Apr 12, 2011 - USA - HealthCanal.com: First clinical trial of gene therapy for pain reported by U-M neurologists</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=354</link>
         <description><![CDATA[New study suggests treatment may provide substantial relief<br /> <br /> Ann Arbor, Mich. In the first clinical trial of gene therapy for treatment of intractable pain, researchers from the University of Michigan Department of Neurology...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=354</guid>
         <pubDate>Tue, 12 Apr 2011 09:22:43 +0100</pubDate>
      </item>
      <item>
         <title>Thu, Mar 31, 2011 - Sweden - Affärsvärlden.se: Börsens stora aktieraketer</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=353</link>
         <description><![CDATA[Stockholmsbörsen bästa långsiktiga aktieraket har stigit med 394 procent på fem år. Kolla in topplistan respektive bottennappen för aktierna du borde köpt. <br /> <br /> <span style="text-decoration: underline;">Topp fem</span><br />...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=353</guid>
         <pubDate>Thu, 31 Mar 2011 09:34:12 +0100</pubDate>
      </item>
      <item>
         <title>Fri, Mar 18, 2011 - Sweden - Sverigesradio.se: Lyckad genterapi mot Parkinson</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=352</link>
         <description><![CDATA[För första gången har forskare visat på människor att genterapi kan fungera mot Parkinsons sjukdom. De har direkt i hjärnan sprutat in felfria gener, som gör att hjärncellerna börjar producera mera av ett ämne som Parkinson-patienter har...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=352</guid>
         <pubDate>Fri, 18 Mar 2011 17:14:34 +0100</pubDate>
      </item>
      <item>
         <title>Fri, Mar 18, 2011 - USA - Medicalnewstoday.com: First Successful Double-Blind Study Of Gene Therapy For Parkinson's Disease</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=351</link>
         <description><![CDATA[A randomized, double-blind gene therapy trial for Parkinson's disease has shown that injection of the glutamic acid decarboxylase (GAD) gene directly into the brain is safe and can significantly improve motor function in patients who are...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=351</guid>
         <pubDate>Fri, 18 Mar 2011 17:13:24 +0100</pubDate>
      </item>
      <item>
         <title>Mon, Feb 07, 2011 - Sweden - Company analysis by Redeye: Diamyd Medical: Crunch time this spring</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=350</link>
         <description><![CDATA["The report for the first quarter of the 2010/11 split financial year contained no great surprises. The financial figures were in line with our estimates. Phase II trials have begun for the companys other drug candidate, NP2. This project...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=350</guid>
         <pubDate>Mon, 07 Feb 2011 09:45:40 +0100</pubDate>
      </item>
      <item>
         <title>Fri, Jan 28, 2011 - Sweden - Bolagsanalys av Redeye: Diamyd Medical: Upp till bevis i vår</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=349</link>
         <description><![CDATA["Rapporten för det första kvartalet i det brutna räkenskapsåret 2010/11 innehöll inga större överraskningar. De finansiella siffrorna var i nivå med våra prognoser. Fas II-studier har inletts med bolagets andra läkemedelskandidat NP2....]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=349</guid>
         <pubDate>Fri, 28 Jan 2011 12:35:42 +0100</pubDate>
      </item>
      <item>
         <title>Tue, Jan 25, 2011 - USA - Diamyd represented at the 2011 JDRF Type 1 Diabetes Research Summit in Washington DC</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=348</link>
         <description><![CDATA[<em>The JDRF Research Summit offers access to information from leading experts in diabetes prevention, treatment and awareness. Each brings a unique perspective, from physicians to scientists and congressional staffers, to medical...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=348</guid>
         <pubDate>Tue, 25 Jan 2011 16:30:59 +0100</pubDate>
      </item>
      <item>
         <title>Mon, Jan 17, 2011 - Sweden - diabetesportalen.se: LADA - i gråzonen mellan typ 2 och typ 1 diabetes</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=347</link>
         <description><![CDATA[Trots att diabetesformen LADA är lika vanlig som typ 1 diabetes är orsakerna bakom i princip okända. Första gången jag kom i kontakt med LADA blev jag häpen när jag insåg hur lite som var känt om denna diabetesform, skriver forskaren Sofia...]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=347</guid>
         <pubDate>Mon, 17 Jan 2011 11:33:34 +0100</pubDate>
      </item>
      <item>
         <title>Mon, Jan 03, 2011 - Sweden - di.se: Diamyd Medical Dagens Aktie 31 dec. 2010</title>
         <link>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=346</link>
         <description><![CDATA[Köpkandidat - Medellång sikt, 30. dec 2010 <br /> <br /> Diamyd Medical B ligger i en stigande trend och fortsatt positiv utveckling innanför denna indikeras. Befinner sig i en rektangelformation mellan stödet på 121 och motståndet på 153....]]></description>
         <guid>http://www.diamyd.com/docs/newsClip.aspx?section=news&amp;UrlID=346</guid>
         <pubDate>Mon, 03 Jan 2011 13:27:25 +0100</pubDate>
      </item>
   </channel>
</rss>
